Zoetis stock lifts 2026 outlook after mixed third quarter

Published on 11/08/2026 at 14:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zoetis stock follows a mixed third quarter, with revenue down but adjusted earnings higher. Management raised its full-year EPS outlook.

Zoetis balances growth and pressure

Third-quarter revenue declined 1 percent, while adjusted diluted EPS rose 3 percent on a reported basis.
U.S. revenue fell 6 percent as companion-animal sales faced pricing, dermatology and generic competition.
Zoetis raised its full-year adjusted diluted EPS guidance to 6.25 to 6.35 dollars.

ZTS, US98978V1035, Illustration mit AI erstellt.

Zoetis reported third-quarter results on Thursday, November 5, showing continued pressure in companion animal products but stronger adjusted earnings. The animal-health company said revenue fell 1 percent year over year to 2.391 billion dollars, while adjusted diluted earnings per share rose 3 percent to 1.75 dollars.

Zoetis stock traded at 71.26 euros on Lang & Schwarz at 1:03 p.m. CET on Saturday, November 7. The quote is a weekend snapshot rather than a live weekday market indication.

Pet products weigh on sales

According to the Zoetis earnings release, U.S. segment revenue decreased 6 percent to 1.2 billion dollars. Companion animal revenue dropped 8 percent, reflecting price sensitivity, competitive pressure in dermatology and generic competition. U.S. livestock revenue increased 5 percent.

International revenue rose 4 percent to 1.1 billion dollars. International livestock revenue increased 8 percent on a reported basis, while companion animal revenue grew 1 percent as parasiticides and osteoarthritis pain products partly offset lower dermatology sales.

Guidance moves higher

Reported net income declined 18 percent to 591 million dollars, and diluted EPS fell 12 percent to 1.44 dollars. The adjusted figures exclude a net impact of 129 million dollars from purchase accounting adjustments, acquisition and divestiture-related costs and other significant items.

Zoetis narrowed its full-year 2026 revenue guidance to 9.220 billion to 9.320 billion dollars. It also raised adjusted net income guidance to 2.600 billion to 2.640 billion dollars and adjusted diluted EPS guidance to 6.25 to 6.35 dollars.

Investors can follow the real-time quote of Zoetis stock for the next tradable market indication.